respiratori
syncyti
viru
rsv
lead
caus
sever
respiratori
diseas
infant
age
time
infect
caus
correl
sever
ill
infant
lack
known
risk
factor
poorli
defin
recruit
cohort
confirm
rsvinfect
infant
simultan
assay
presenc
resid
airway
microbiota
molecular
statu
airway
use
novel
method
rigor
statist
analys
identifi
molecular
airway
gene
express
signatur
sever
ill
domin
excess
chemokin
express
global
rrna
sequenc
confirm
associ
h
influenza
clinic
sever
interestingli
adjust
h
influenza
gene
express
analysi
reveal
associ
sever
airway
lymphocyt
accumul
explor
relationship
airway
gene
express
time
onset
clinic
symptom
reveal
robust
acut
activ
interferon
ifn
signal
absent
subject
sever
ill
final
explor
relationship
ifn
activ
airway
gene
express
product
rsv
infect
use
novel
vitro
model
bona
fide
pediatr
human
airway
epitheli
cell
interestingli
block
ifn
signal
ifn
ligand
product
cell
lead
increas
viral
infect
data
reveal
acut
airway
interferon
respons
physiolog
relev
context
infant
rsv
infect
may
target
therapeut
intervent
addit
airway
gene
express
signatur
defin
may
use
biomark
efficaci
intervent
respons
right
reserv
reus
allow
without
permiss
respiratori
syncyti
viru
rsv
lead
caus
sever
respiratori
diseas
infant
age
time
infect
caus
correl
sever
ill
infant
lack
known
risk
factor
poorli
defin
recruit
cohort
confirm
rsvinfect
infant
simultan
assay
presenc
resid
airway
microbiota
molecular
statu
airway
use
novel
method
rigor
statist
analys
identifi
molecular
airway
gene
express
signatur
sever
ill
domin
excess
chemokin
express
global
rrna
sequenc
confirm
associ
h
influenza
clinic
sever
interestingli
adjust
h
influenza
gene
express
analysi
reveal
associ
sever
airway
lymphocyt
accumul
explor
relationship
airway
gene
express
time
onset
clinic
symptom
reveal
robust
acut
activ
interferon
ifn
signal
absent
subject
sever
ill
final
explor
relationship
ifn
activ
airway
gene
express
product
rsv
infect
use
novel
vitro
model
bona
fide
pediatr
human
airway
epitheli
cell
interestingli
block
ifn
signal
ifn
ligand
product
cell
lead
increas
viral
infect
data
reveal
acut
airway
interferon
respons
physiolog
relev
context
infant
rsv
infect
may
target
therapeut
intervent
addit
airway
gene
express
signatur
defin
may
use
biomark
efficaci
intervent
respons
respiratori
syncyti
viru
rsv
neg
strand
rna
viru
pneumovirida
famili
import
caus
respiratori
tract
infect
infanc
caus
annual
winter
outbreak
us
us
approxim
half
million
newborn
infect
first
winter
hospit
addit
seen
emerg
depart
physician
offic
respect
rsv
infect
mortal
uncommon
us
death
annual
howev
develop
countri
estim
annual
rsv
caus
thousand
death
million
case
sever
acut
lower
respiratori
ill
million
hospit
children
year
age
current
avail
vaccin
rsv
infant
although
sever
candid
vaccin
clinic
trial
long
establish
major
risk
factor
sever
ill
includ
prematur
bronchopulmonari
dysplasia
cyanot
heart
diseas
neuromuscular
diseas
immun
compromis
howev
approxim
hospit
infant
us
overt
risk
factor
sever
ill
although
young
age
infect
environment
influenc
tobacco
smoke
exposur
viral
load
strain
low
level
matern
deriv
rsvneutral
antibodi
well
multitud
genet
host
factor
associ
sever
diseas
studi
like
play
pivot
role
elimin
viru
replic
well
enhanc
moder
inflammatori
respons
aspir
assess
predict
infant
rsv
effect
sever
studi
comprehens
studi
design
identifi
factor
associ
diseas
sever
full
term
healthi
infant
less
month
age
undergo
primari
rsv
infect
report
analyz
gene
express
nasal
respiratori
epitheli
cell
addit
influenc
respiratori
microbiota
relat
ill
sever
primari
rsv
infect
addit
describ
develop
vitro
model
rsv
infect
explor
relationship
interferon
activ
airway
cell
gene
express
product
rsv
infect
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
rsv
effect
sever
aspir
studi
three
winter
rochest
ny
previous
describ
infant
less
month
age
time
primari
rsv
infect
came
one
three
cohort
infant
prospect
enrol
birth
follow
develop
rsv
infect
infant
enrol
upon
hospit
rsv
infect
infant
identifi
rsv
emerg
room
physician
offic
manag
outpati
subject
previous
healthi
fullterm
infant
gestat
age
week
born
may
previou
spring
infant
hospit
apnea
exclud
well
known
highrisk
condit
research
subject
review
board
univers
rochest
rochest
gener
hospit
approv
studi
parent
provid
written
inform
consent
rsv
infect
identifi
revers
transcript
polymeras
chain
reaction
rtpcr
nasal
swab
follow
confirm
rsv
infect
studi
subject
underw
standard
evalu
three
time
point
first
ill
visit
occur
within
hour
rsv
diagnosi
second
visit
day
ill
onset
final
visit
ill
day
demograph
clinic
data
collect
visit
first
third
visit
nasal
swab
collect
one
nostril
analysi
respiratori
microbiota
follow
collect
nasal
epitheli
cell
contralater
nostril
previous
describ
briefli
wash
nare
ml
steril
salin
remov
mucu
cellular
debri
mid
turbin
brush
second
flock
swab
copan
catalog
copan
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
murrieta
ca
remov
respiratori
epitheli
cell
swab
immedi
place
ml
rna
protect
maintain
c
cell
recov
filtrat
homogen
rna
lysi
buffer
describ
descript
characterist
studi
cohort
report
tabl
sever
clinic
ill
patient
defin
global
respiratori
sever
score
grss
briefli
global
respiratori
sever
score
grss
defin
weight
combin
clinic
measur
includ
gener
appear
presenc
rale
wheez
cyanosi
retract
lethargi
poor
air
movement
maxim
ageadjust
respiratori
rate
worst
room
air
oxygen
satur
grss
defin
continu
scale
highli
correl
need
hospit
secondari
analys
sever
ill
dichotom
defin
grss
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
rna
isol
assess
qualiti
quantiti
averag
yield
ng
per
sampl
ng
total
rna
amplifi
use
smarter
ultra
low
amplif
kit
clontech
mountain
ca
pcr
amplif
gener
suffici
cdna
librari
construct
amplifi
cdna
quantif
determin
qubit
flouromet
life
technolog
grand
island
ny
qualiti
assess
use
agil
bioanalyz
santa
clara
ca
librari
construct
perform
use
nexteraxt
librari
kit
illumina
san
diego
ca
ng
input
amplifi
cdna
per
manufactur
recommend
nextera
librari
quantifi
qubit
flouromet
life
technolog
grand
island
ny
qualiti
assess
use
agil
tape
station
santa
clara
ca
librari
sequenc
illumina
illumina
san
diego
ca
gener
million
singl
end
read
per
sampl
sequenc
align
star
human
genom
version
normal
fpkm
use
follow
nonspecif
filter
strategi
remov
gene
low
express
valu
indistinguish
background
signal
first
comput
sampl
quantil
express
level
th
gene
gene
next
defin
trim
maximum
logexpress
log
remov
gene
equival
filter
step
total
gene
select
analys
remov
fifteen
sampl
total
number
map
read
less
million
ten
sampl
low
averag
correl
sampl
sampl
select
analys
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
object
metric
data
sampl
suggest
high
degre
qualiti
supplement
figur
similar
previous
publish
due
fact
studi
span
three
year
sampl
process
six
librari
batch
notic
signific
batch
effect
total
number
map
read
sampl
addit
use
analysi
varianc
anova
ftest
fals
discoveri
rate
fdr
control
level
found
gene
express
transcriptom
significantli
differ
mean
express
across
batch
base
observ
use
combat
remov
batch
effect
expect
appli
combat
gene
signific
batch
effect
base
anova
ftest
avoid
spuriou
find
due
outlier
also
winsor
data
level
specif
observ
less
greater
data
replac
valu
sampl
quantil
also
remov
gene
express
winsor
half
sampl
n
summari
total
gene
express
profil
pass
qualiti
control
procedur
select
investig
univari
multivari
gene
signific
analys
conduct
use
r
packag
limma
robust
mestim
nine
covari
global
respiratori
sever
score
grss
sex
race
gestat
age
visit
age
time
sinc
diseas
onset
time
smoke
exposur
viru
coinfect
bacteri
colon
investig
via
univari
analys
associ
singl
covari
gene
express
estim
follow
univari
analys
conduct
multivari
analysi
includ
nine
signific
clinic
variabl
addit
also
tri
simplifi
multivari
regress
model
five
signific
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
covari
time
grss
sex
race
bacteri
colon
identifi
full
multivari
regress
analys
case
regress
ttest
use
determin
signific
linear
associ
covari
gene
express
level
benjaminihochberg
multipl
test
correct
appli
control
fals
discoveri
rate
fdr
initi
diagnosi
rsv
infect
confirm
rtpcr
describ
array
card
tac
technolog
use
detect
common
respiratori
pathogen
initi
nasal
swab
well
hemophilu
influenza
streptococcu
pneumonia
previous
describ
pneumonia
b
pertussi
homini
u
ureaplasma
also
includ
card
detect
human
rnase
p
gene
posit
control
confirm
presenc
cellular
materi
airway
microbiota
analysi
infant
perform
essenti
previous
describ
briefli
nasal
specimen
collect
anterior
nare
acut
ill
visit
rrna
amplifi
total
genom
dna
extract
swab
sequenc
x
illumina
miseq
illumina
san
diego
ca
rrna
bacteri
sequenc
read
assess
qualiti
analyz
use
phylogenet
oper
taxonom
unit
otu
method
quantit
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
insight
microbi
ecolog
qiim
softwar
version
purpos
otu
rel
abund
analysi
raw
otu
tabl
normal
use
cumul
sum
stabil
method
metagenomicseq
r
packag
limit
analys
subject
transcriptom
microbiom
sampl
avail
antibiot
data
avail
total
oper
taxonom
unit
otu
filter
detect
subject
neither
genu
speci
discern
otu
use
analysi
linear
regress
grss
outcom
conduct
estim
associ
grss
otu
control
visit
age
result
show
two
highli
correl
otu
haemophilu
taxa
speci
influenza
speci
unknown
analys
combin
otu
h
influenza
similar
regress
perform
addit
clinic
variabl
next
test
univari
associ
grss
gene
express
adjust
visit
age
identifi
gene
associ
grss
base
regress
ttest
unadjust
p
valu
final
multivari
linear
regress
conduct
grss
outcom
variabl
includ
visit
age
combin
h
influenza
select
gene
express
profil
nasal
wash
sampl
test
cytokin
chemokin
use
r
system
human
luminex
human
assay
minneapoli
mn
magnet
bead
prepar
cytokin
standard
procedur
assay
carri
follow
manufactur
suggest
protocol
bead
read
use
magpix
luminex
corp
austin
tx
xponent
softwar
luminex
corp
austin
tx
use
instrument
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
control
data
acquisit
data
analysi
cytokin
chemokin
measur
trail
statist
analysi
carri
nonpair
sampl
mannwhitney
u
test
gene
identifi
differenti
express
subsequ
use
canon
pathway
identif
upstream
regul
analysi
use
ingenu
pathway
analysi
ipa
http
analysisingenuitycompa
ontolog
phenotyp
function
enrich
analysi
use
toppgen
suit
http
toppgenecchmcorg
celltyp
enrich
identif
use
cten
http
wwwinfluenza
xorgjshoemakerctenadvancedexamplephp
quantit
realtim
polymeras
chain
reaction
qpcr
perform
use
aliquot
rna
sampl
obtain
sequenc
cdna
gener
approxim
ng
rna
use
iscript
cdna
synthesi
kit
biorad
hercul
ca
accord
manufactur
recommend
pcr
perform
use
genespecif
primer
set
gene
express
level
calcul
rel
ppia
cyclophilin
use
ddct
method
pediatricinf
human
lung
epitheli
phle
cell
gener
transplant
donor
qualiti
lung
lungmap
program
recent
describ
briefli
fresh
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
lung
tissu
digest
proteas
cocktail
singl
cell
suspens
wash
time
dpb
supplement
penicillinstreptomycin
gibco
gentamicin
amphotericin
b
centrifug
xg
minut
grown
sagm
supplement
fb
hour
nonadher
cell
remov
epitheli
cell
expand
fibroblastlik
cell
remov
treatment
trypsin
edta
dpb
room
temperatur
establish
airliquid
interfac
cultur
cell
seed
rat
tail
collagen
coat
transwel
insert
well
pet
membran
pore
size
mm
diamet
hour
cultur
medium
chang
mixtur
begmdmem
cell
reach
confluenc
appropri
resist
ohm
transfer
ali
remov
apic
medium
upon
transit
ali
cell
maintain
pneumacultali
medium
contain
supplement
hydrocortison
accord
manufactur
instruct
ali
cultur
differenti
day
ali
viru
infect
rsv
strain
gift
dr
mark
peepl
gener
cell
previous
describ
alidifferenti
phle
cultur
wash
twice
pb
infect
apic
rsv
multipl
infect
one
hour
inoculum
remov
apic
surfac
rins
pb
twice
remov
unbound
viral
particl
infect
phle
maintain
ali
hour
monitor
infect
use
fluoresc
microscop
hour
cell
harvest
rna
isol
subject
qpcr
describ
infect
quantifi
measur
gfp
fluoresc
imagej
softwar
http
imagejnihgovij
rsvm
gene
quantif
use
realtim
polymeras
chain
reaction
qpcr
indic
interferon
ligand
ngml
ngml
r
system
provid
phle
cell
hour
prior
rsv
infect
maintain
throughout
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
infect
experi
indic
interferon
signal
inhibitor
ruxolitinib
selleck
chemic
provid
phle
cell
hour
prior
rsv
infect
maintain
throughout
infect
experi
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
sought
understand
target
organ
resid
cell
respons
primari
rsv
infect
first
year
life
infant
display
full
spectrum
ill
sever
implement
recent
describ
nasal
cell
sampl
procedur
measur
infant
airway
transcript
respons
rsv
infect
infant
enrol
aspir
studi
satisfactori
nasal
sampl
gene
express
result
analysi
demograph
data
infant
describ
tabl
infant
rang
month
age
mean
age
month
equal
distribut
gender
sixtythre
hospit
infect
manag
outpati
subject
assign
continu
global
respiratori
sever
score
grss
previous
describ
associ
sever
defin
hospit
grss
rsv
strain
familyreport
environment
tobacco
smoke
exposur
presenc
viral
pathogen
bacteri
colon
base
posit
rtpcr
tabl
transcriptom
analysi
airway
sampl
collect
subject
acut
phase
rsv
infect
includ
assess
gene
follow
standard
qcbase
sampl
gene
filter
previous
describ
gene
express
data
procedur
enrich
canon
eg
epcam
upper
airwayspecif
eg
bpif
muc
marker
gene
lower
level
express
leukocyt
marker
supplement
figur
initi
explor
relationship
gene
express
demograph
variabl
univari
analysi
indic
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
mani
variabl
associ
substanti
differ
gene
express
appropri
adjust
multipl
test
tabl
previous
report
presenc
known
bacteri
pathogen
larg
impact
airway
gene
express
gene
appear
driven
presenc
pneumonia
gene
moraxella
h
influenza
identifi
standard
rtpcr
microbiolog
diagnost
assay
tac
card
describ
notabl
time
elaps
onset
clinic
symptom
time
also
major
impact
gene
express
gene
interestingli
presenc
addit
pathogen
acut
infect
aggreg
significantli
associ
clinic
sever
p
tabl
gene
express
display
interest
associ
clinic
sever
gene
margin
identifi
significantli
associ
sever
adjust
multipl
test
adjust
sever
defin
dichotom
mild
sever
sever
defin
continu
grss
gene
significantli
associ
grss
order
better
defin
gene
express
chang
independ
associ
grss
complet
multivari
analysi
includ
sex
race
bacteri
colon
time
sinc
onset
clinic
symptom
model
analysi
identifi
gene
significantli
associ
diseas
sever
supplement
figur
multivari
model
gene
associ
time
sinc
ill
onset
gene
associ
presenc
bacteri
pathogen
tabl
gene
significantli
associ
sever
univari
data
shown
multivari
model
rich
chemokin
cytokin
interleukinrel
molecul
supplement
figur
ontolog
analysi
gene
set
identifi
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
multipl
biolog
function
relat
viral
infect
fig
confirm
valid
approach
data
interestingli
analysi
suggest
gene
express
biomark
sever
associ
pneumonia
fig
observ
consist
lower
respiratori
track
pathogenesi
sever
rsv
infect
also
support
util
upper
airway
transcriptom
surrog
identifi
relev
diseas
mechan
lung
also
assess
cell
signatur
sever
associ
gene
express
biomark
unlik
epitheli
predomin
signatur
healthi
asymptomat
infant
sever
clinic
respons
rsv
infect
associ
signatur
multipl
blood
inflammatori
cell
well
smooth
muscl
fig
predomin
cell
signatur
relat
myeloid
lineag
pathway
analysi
confirm
increas
express
myeloid
cellrel
gene
sever
case
also
strongli
implic
respons
fig
valid
severityassoci
gene
express
chang
transcript
level
qpcr
rna
sampl
subject
supplement
tabl
also
perform
multiplex
elisa
analysi
use
nasal
wash
obtain
immedi
prior
nasal
brush
sampl
collect
confirm
biolog
impact
transcript
chang
shown
figur
valid
signific
differ
level
multipl
inflammatori
biomark
associ
sever
eg
nonsignific
differ
other
eg
recent
work
other
demonstr
specif
presenc
h
influenza
airway
correl
sever
clinic
respons
infant
rsv
complet
unbias
microbiota
analysi
airway
subject
use
rrna
sequenc
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
figur
otu
significantli
associ
sever
follow
adjust
multipl
test
cohort
supplement
tabl
seen
figur
although
great
degre
variat
rel
abund
h
influenza
exist
within
group
sever
affect
infant
averag
much
higher
abund
although
undefin
use
rrna
data
presum
repres
nontyp
h
influenza
nthi
sinc
incid
h
influenza
type
b
uncommon
interestingli
otu
includ
h
influenza
significantli
associ
age
suggest
nasal
microbi
commun
evolv
extens
infanc
cohort
given
substanti
impact
presenc
bacteri
pathogen
airway
gene
express
asymptomat
symptomat
subject
tabl
singular
associ
h
influenza
sever
sought
identifi
severityassoci
gene
express
independ
impact
h
influenza
perform
multivari
analysi
similar
describ
includ
rel
abund
h
influenza
model
identifi
gene
significantli
associ
grss
independ
presenc
h
influenza
visit
age
analysi
gene
set
reveal
mani
gene
pathway
supplement
figur
cell
type
identifi
analysi
includ
h
influenza
howev
ontolog
analysi
gene
set
identifi
greater
associ
bacteri
infect
fig
addit
includ
h
influenza
note
cell
type
signatur
attenu
myeloid
lineag
inflat
lymphocyt
lineag
fig
data
suggest
h
influenza
influenc
clinic
sever
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
rsv
infect
infant
modifi
immun
system
natur
inflammatori
respons
indic
sampl
collect
singl
time
acut
phase
infect
follow
onset
clinic
symptom
time
appear
major
impact
gene
express
tabl
supplement
figur
interrog
gene
express
biomark
time
better
understand
natur
airway
respons
infect
may
relat
clinic
diseas
sever
interestingli
pathway
analysi
fig
indic
strong
signal
increas
mtor
signal
alter
mitochondri
oxid
phosphoryl
activ
time
less
surprisingli
also
indic
diminish
innat
interferon
signal
time
gene
contribut
signatur
includ
multipl
intracellular
ifn
signal
molecul
ligand
receptor
perform
exploratori
analysi
ifn
pathwayrel
gene
better
understand
express
pattern
subject
reveal
surpris
dichotomi
sever
nonsever
subject
express
ifn
pathway
gene
identifi
analysi
fig
associ
sever
like
identifi
prior
analysi
signific
increas
express
note
nonsever
subject
note
first
day
follow
onset
clinic
symptom
wherea
littl
evid
interferon
signal
note
subject
later
time
point
qpcr
valid
mani
gene
support
complex
relationship
gene
express
clinic
sever
ontogeni
ill
supplement
tabl
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
analysi
potenti
regul
gene
express
respons
implic
type
p
type
p
ligand
well
canon
interferonassoci
transcript
factor
p
due
low
level
express
mani
ifn
ligand
receptor
gene
subject
remov
analyt
data
set
part
procedur
avoid
fals
discoveri
increas
statist
power
perform
posthoc
analysi
ifn
ligand
express
found
evid
high
level
express
type
ligand
particularli
nonsever
subject
sever
subject
fig
use
multiplex
elisa
nasal
wash
measur
airway
ifn
ligand
product
first
day
follow
onset
clinic
symptom
confirm
higher
level
ifnb
ifnl
nonsever
subject
fig
data
suggest
interferon
signal
respons
andor
interferon
product
within
first
day
infect
contribut
establish
clinic
sever
rsv
infect
infant
interferon
product
known
ubiquit
host
respons
suppress
viral
infect
role
mediat
sever
rsv
ill
infant
unclear
viru
activ
suppress
host
protect
mechan
via
rsv
gene
product
sinc
data
upper
respiratori
system
may
accur
reflect
import
pathway
lower
airway
diseas
mechan
contribut
clinic
sever
sought
test
whether
pathway
evid
rna
level
test
induct
express
sever
associ
biomark
phle
surprisingli
model
portion
vivo
respons
infect
found
gene
regul
abl
demonstr
rsv
infectionrel
increas
express
rna
level
test
effect
gainand
lossoffunct
manipul
ifn
activ
rsv
infect
phle
cell
fig
expect
pretreat
phle
cell
type
figur
c
type
iii
supplement
figur
figur
critic
surprisingli
rux
potenti
viral
infect
block
ifn
ligand
product
fig
data
indic
ifn
signal
necessari
suffici
suppress
express
correl
rsvinfect
infant
clinic
sever
primari
cultur
pediatr
lung
epitheli
cell
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
studi
address
critic
knowledg
gap
understand
mechan
involv
infant
respiratori
diseas
rare
opportun
comprehens
interrog
resid
cell
respons
target
organ
appli
recent
develop
method
facilit
comprehens
molecular
analysi
airway
amen
infant
subject
whether
clinic
well
ill
appli
infant
subject
acut
phase
rsv
ill
data
support
util
biospecimen
reason
surrog
pathophysiolog
respons
occur
lower
airway
fig
addit
provid
novel
insight
diseaserel
respons
relat
sever
clinic
symptom
fig
presenc
cooccur
microb
fig
timelin
clinic
symptom
fig
also
leverag
novel
physiolog
vitro
system
emul
cellular
respons
viral
infect
pediatr
human
lung
epitheli
cell
phle
use
model
system
valid
relationship
rsvinduc
ifnrel
intracellular
signal
sever
infect
relev
target
cell
viru
fig
identifi
gene
express
correl
sever
popul
surpris
identifi
mani
chemokin
reflect
robust
inflammatori
respons
fig
somewhat
insight
ontolog
analysi
implic
robust
chang
signal
sever
patient
compar
milder
form
ill
specif
airway
likewis
data
implic
airway
chang
signal
alter
matrix
metalloproteinas
activ
addit
novel
insight
data
suggest
natur
inflammatori
respons
airway
differ
infant
sever
rsvassoci
ill
particular
data
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
indic
enrich
myeloid
cell
observ
warrant
investig
test
potenti
mechanist
role
interest
understand
role
airway
microbiota
defin
clinic
respons
rsv
infant
fail
find
strong
associ
presenceabs
microbi
pathogen
sever
howev
confirm
report
publish
studi
indic
higher
burden
h
influenza
infant
sever
clinic
symptom
requir
hospit
fig
although
taxa
associ
airway
gene
express
somewhat
surpris
find
otu
significantli
associ
sever
worth
know
ribosom
rna
sequenc
abl
identifi
pneumonia
speci
level
given
prior
studi
reveal
larg
impact
microbiota
upon
gene
express
airway
studi
interrelationship
airway
microbiom
airway
gene
express
clinic
sever
gener
analys
confirm
exist
known
pathogen
particularli
bacteria
strongli
associ
gene
express
asymptomat
symptomat
infant
consid
specif
effect
microbiotah
flu
relationship
gene
express
rsv
sever
result
consist
h
flu
alter
natur
inflammatori
respons
myeloidpredomin
lymphocytepredomin
data
provid
current
untest
hypothesi
potenti
mechan
wherebi
h
influenza
contribut
sever
respons
molecular
cellular
level
focu
current
investig
identif
distinct
timedepend
chang
ifn
signal
compar
sever
affect
versu
nonsever
affect
infant
novel
consist
fundament
biolog
viral
respons
perhap
readili
appar
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
prior
studi
focus
sever
affect
infant
compar
noninfect
infant
show
limit
evid
activ
pathway
way
studi
focus
upon
clinic
sever
cohort
infect
rsv
provid
opportun
differ
insight
also
draw
attent
narrow
time
window
differ
ifn
group
evid
fig
even
data
differ
express
reach
level
statist
signific
without
restrict
analys
first
day
follow
onset
clinic
symptom
vitro
data
indic
ifn
necessari
suffici
control
rsv
infect
mammalian
cell
particularli
novel
valid
hypothesi
gener
vivo
data
howev
feel
import
demonstr
mechan
causal
infect
truli
physiolog
model
bona
fide
human
pediatr
lung
epitheli
cell
vitro
data
also
partial
reveal
complex
vivo
respons
subset
gene
express
correl
sever
valid
suggest
severityassoci
gene
express
respons
requir
result
addit
cell
type
eg
leukocyt
like
modifi
microbi
commun
model
state
respons
one
focu
futur
experiment
emphas
primari
observ
sever
associ
ifn
ligand
product
estim
level
signal
activ
airway
distinct
could
due
low
level
ligand
product
even
infant
mild
clinic
symptom
howev
could
show
differ
ifn
ligand
express
rna
protein
level
fig
initi
discoveri
phase
rnaseq
data
analysi
convers
distinct
could
support
logic
conclus
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
downstream
signal
critic
protect
effect
viralinduc
ifn
product
interpret
support
vitro
data
fig
block
ifn
receptor
signal
suffici
potenti
widespread
viral
infect
even
presenc
ifn
ligand
express
regardless
induct
type
type
iii
ifn
occur
vivo
vitro
rel
role
type
versu
type
iii
ifn
vivo
clear
time
type
type
iii
ifn
appear
express
nonsever
subject
acut
phase
ill
fig
evalu
human
biospecimenderiv
rnaseq
data
util
multipl
analyt
statist
approach
effort
thoroughli
interrog
vivo
respons
reflect
critic
appli
appropri
conserv
correct
multipl
test
case
believ
use
analyt
approach
justifi
provid
distinct
yet
import
insight
univari
analys
use
estim
direct
associ
one
covari
individu
gene
analys
easi
perform
interpret
suffer
potenti
collinear
issu
among
covari
use
initi
explor
overal
pattern
associ
clinic
covari
transcriptom
profil
hand
multivari
model
consid
influenc
sever
covari
gene
express
simultan
therefor
estim
associ
respons
variabl
given
covari
less
like
affect
unmodel
interdepend
arguabl
multivari
model
natur
multipl
univari
model
close
approxim
complex
biolog
process
collect
influenc
transcriptom
said
caution
must
exercis
use
complex
multivari
model
uninform
covari
includ
multivari
model
may
mask
true
associ
reduc
statist
power
detect
inform
associ
seriou
issu
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
potenti
collinear
among
covari
may
prevent
model
certain
combin
covari
produc
unstabl
estim
therefor
believ
practic
strategi
first
use
univari
analys
identifi
subset
import
covari
use
build
lean
robust
multivari
model
acknowledg
studi
without
limit
focus
effort
identifi
gene
express
respons
distinguish
infant
sever
affect
rsv
infect
compar
infant
sever
ill
includ
noninfect
control
therefor
unabl
address
specif
respons
observ
report
studi
group
storch
unpublish
suggest
respons
viral
infect
identifi
occur
much
smaller
magnitud
describ
anoth
limit
associ
natur
data
present
one
must
use
caution
resist
presum
vivo
correl
observ
report
mechanist
rather
hypothesi
gener
case
abl
show
mechanist
relationship
specif
genespathway
magnitud
viral
infect
fig
importantli
vitro
model
provid
physiolog
relev
system
pursu
mechanist
hypothes
result
analysi
vivo
data
howev
model
also
limit
current
isol
epitheli
cell
respons
data
clearli
suggest
involv
leukocyt
monocyt
vivo
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
display
distinct
pattern
tempor
express
rsvinfect
infant
significantli
higher
express
infant
mild
compar
sever
symptom
type
iiii
interferon
ligand
gene
express
time
day
assess
separ
mild
sever
affect
infant
c
shown
estim
express
level
red
equal
higher
express
individu
ligand
gene
day
follow
onset
clinic
symptom
data
consist
earli
activ
type
iiii
interferon
pathway
activ
mild
subject
multiplex
elisa
analysi
nasal
wash
rsv
infect
infant
confirm
product
type
iiii
interferon
ligand
increas
infant
sever
clinic
symptom
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
figur
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
